Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Mullen

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Journal of Molecular Biology|May 9, 1998
A single mutation disrupts the pH-dependent dimerization of glycinamide ribonucleotide transformylaseC A Mullen, P A Jennings
Journal of Post Anesthesia Nursing|August 1, 1990
Laryngospasm-induced pulmonary edema: case reportS J Fetzer-Fowler, C A Mullen
Cellular Immunology|March 1, 1989
Highly immunogenic regressor tumor cells can prevent development of postsurgical tumor immunityC A Mullen, D A Rowley, H Schreiber
Bone Marrow Transplantation|May 16, 2003
Analysis of immunodominance among minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantationS Mori, H El-Baki, C A Mullen
Cancer Research|March 15, 1996
Treatment of microscopic pulmonary metastases with recombinant autologous tumor vaccine expressing interleukin 6 and Escherichia coli cytosine deaminase suicide genesC A Mullen, D Petropoulos, R M Lowe
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1992
Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection systemC A Mullen, M Kilstrup, R M Blaese
Bone Marrow Transplantation|August 28, 1998
Allogeneic peripheral blood stem cell transplantation for active hemophagocytic lymphohistiocytosisK W Chan, C A Mullen, M Korbling
Blood|March 25, 2000
Immunization of allogeneic bone marrow transplant recipients with tumor cell vaccines enhances graft-versus-tumor activity without exacerbating graft-versus-host diseaseL D Anderson, C A Savary, C A Mullen
Blood|November 15, 1993
Splenectomy and/or bone marrow transplantation in the management of the Wiskott-Aldrich syndrome: long-term follow-up of 62 casesC A Mullen, K D Anderson, R M Blaese
Human Gene Therapy|June 1, 1994
Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expressionL A Couture, C A Mullen, R A Morgan
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Journal of Molecular Biology|May 9, 1998
A single mutation disrupts the pH-dependent dimerization of glycinamide ribonucleotide transformylaseC A Mullen, P A Jennings
Journal of Post Anesthesia Nursing|August 1, 1990
Laryngospasm-induced pulmonary edema: case reportS J Fetzer-Fowler, C A Mullen
Cellular Immunology|March 1, 1989
Highly immunogenic regressor tumor cells can prevent development of postsurgical tumor immunityC A Mullen, D A Rowley, H Schreiber
Bone Marrow Transplantation|May 16, 2003
Analysis of immunodominance among minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantationS Mori, H El-Baki, C A Mullen
Cancer Research|March 15, 1996
Treatment of microscopic pulmonary metastases with recombinant autologous tumor vaccine expressing interleukin 6 and Escherichia coli cytosine deaminase suicide genesC A Mullen, D Petropoulos, R M Lowe
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1992
Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection systemC A Mullen, M Kilstrup, R M Blaese
Bone Marrow Transplantation|August 28, 1998
Allogeneic peripheral blood stem cell transplantation for active hemophagocytic lymphohistiocytosisK W Chan, C A Mullen, M Korbling
Blood|March 25, 2000
Immunization of allogeneic bone marrow transplant recipients with tumor cell vaccines enhances graft-versus-tumor activity without exacerbating graft-versus-host diseaseL D Anderson, C A Savary, C A Mullen
Blood|November 15, 1993
Splenectomy and/or bone marrow transplantation in the management of the Wiskott-Aldrich syndrome: long-term follow-up of 62 casesC A Mullen, K D Anderson, R M Blaese
Human Gene Therapy|June 1, 1994
Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expressionL A Couture, C A Mullen, R A Morgan
Pageof 7